Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
Thrombotic thrombocytopenic purpura (TTP) is a dramatic intravascular platelet-clumping disorder characterized by microangiopathic hemolytic anemia, thrombocytopenia, neurologic abnormalities, renal insufficiency and fever. TTP is a rare disease but is almost always fatal if untreated. More than 80% of patients survive with plasma therapy. In healthy individuals, the proteolytic cleavage of ultralarge von Willebrand factor (vWF) multimers prevents spontaneous clumping of platelets in the microcirculation. Patients with TIP have either severe congenital deficiency of von Willebrand factor-cleaving protease (vWF-cp), or have autoantibodies that inhibit the protease. Determination of vWF-cp levels in patient plasma helps to distinguish between TTP and other thrombotic microangiopathies with similar clinical signs and symptoms. vWF-cp is a member of the ADAMTS family of metalloproteases and has been designated ADAMTS13.
Furlan
Miha
M
Central Hematology Laboratory, University Hospital, Inselspital, Bern, Switzerland. furlan@swissonline.ch
D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; D006463:Hemolytic-Uremic Syndrome / Q000175:diagnosis / Q000201:enzymology / Q000276:immunology / Q000628:therapy; D006801:Humans; D008666:Metalloendopeptidases / Q000172:deficiency / Q000378:metabolism*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000175:diagnosis / Q000201:enzymology* / Q000276:immunology / Q000628:therapy; D014481:United States / Q000453:epidemiology
D051722:ADAM Proteins; D008666:Metalloendopeptidases; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human